|
Volumn 12, Issue 12, 2010, Pages 1023-1030
|
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 CARBOXYFLUORESCEIN;
BREAST CANCER RESISTANCE PROTEIN;
DACTINOMYCIN;
GLUTATHIONE;
MITOXANTRONE;
MULTIDRUG RESISTANCE PROTEIN 1;
N ETHYLMALEIMIDE;
NITRIC OXIDE;
PACLITAXEL;
PROTEIN P53;
RHODAMINE 123;
SAQUINAVIR;
VERAPAMIL;
VERLUKAST;
VINCRISTINE;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
C57BL 6 MOUSE;
CANCER CELL;
CANCER CELL CULTURE;
CANCER COMBINATION CHEMOTHERAPY;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CELL VIABILITY;
CONTROLLED STUDY;
GLIOMA CELL;
MOUSE;
MULTIDRUG RESISTANCE;
MUTATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SENSITIZATION;
UPREGULATION;
|
EID: 78649896393
PISSN: 15228002
EISSN: 14765586
Source Type: Journal
DOI: 10.1593/neo.10856 Document Type: Article |
Times cited : (55)
|
References (4)
|